Filing Flows › ESCO Technologies (ESE) › Q3 FY26 › vs Q3 FY25
ESCO Technologies (ESE) Q3 FY26 vs Q3 FY25 (year over year)
ESCO Technologies's revenue rose $42.7M (+14%) from $296M in Q3 FY25 to $339M in Q3 FY26. The biggest changes: Aerospace and Defense +$31.9M (+23%); USG +$7.6M (+8%); Test +$3.2M (+5%). Operating margin 12.1% against 11.2% (+0.9 pts).
ESCO Technologies, Q3 FY26: revenue $339M (+14% year over year), operating margin 12.1%, net earnings $32.7M, operating cash flow $58.8M. The chart draws each line against Q3 FY25, the increases inside each band.
Margins
| Q3 FY26 | Q3 FY25 | Change | |
|---|---|---|---|
| Operating margin | 12.1% | 11.2% | +0.9 pts |
| Net margin | 9.7% | 8.8% | +0.9 pts |
| Free cash flow margin | 14.0% | 21.7% | -7.8 pts |
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Aerospace and Defense | $168M | $136M | $31.9M | +23% |
| USG | $100M | $92.4M | $7.6M | +8% |
| Test | $70.9M | $67.7M | $3.2M | +5% |
| Revenue | $339M | $296M | $42.7M | +14% |
| Operating profit | $41.0M | $33.1M | $7.9M | +24% |
| Costs & expenses | $298M | $263M | $34.8M | +13% |
| Pre-tax earnings | $41.0M | $34.4M | $6.6M | +19% |
| Cost of revenue | $198M | $174M | $23.2M | +13% |
| SG&A | $71.0M | $62.0M | $9.0M | +14% |
| Other operating costs | $29.6M | $26.9M | $2.7M | +10% |
| Net earnings | $32.7M | $26.1M | $6.7M | +26% |
| Income tax | $8.2M | $8.3M | −$95K | -1% |
| Depreciation & amortization | $26.7M | $22.4M | $4.4M | +20% |
| Share-based compensation | $3.6M | $2.6M | $1.0M | +39% |
| Working capital & other | $4.3M | −$22.7M | $27.0M | — |
| Operating cash flow | $58.8M | $73.7M | −$15.0M | -20% |
| Free cash flow (OCF − capex) | $47.3M | $64.4M | −$17.1M | -26% |
| Capital expenditures | $11.4M | $9.3M | $2.1M | +22% |
Questions
How much did ESCO Technologies's revenue grow year over year in Q3 FY26?
ESCO Technologies's revenue rose $42.7M (+14%) from $296M in Q3 FY25 to $339M in Q3 FY26.
What drove ESCO Technologies's revenue change in Q3 FY26?
Aerospace and Defense +$31.9M (+23%); USG +$7.6M (+8%); Test +$3.2M (+5%).